
Yan Leyfman, MD, is a physician-scientist in hematology and oncology with a subspecialty focus on hematologic oncology, cellular immunotherapies, gene therapy, early drug development, AI and the management of complex cancer care. His research centers on cellular immunotherapies such as CAR T, cancer immunology, and translational oncology. During the pandemic, he served as Director of the Immunology Division for the Global COVID-19 Taskforce and co-founded MedNews Week to expand access to medical education; he also serves on the executive committee of Music Beats Cancer. His honors include ASCO’s 40 Under 40 Emerging Leaders in Cancer, the International Hero in Healthcare distinction, the Conquer Cancer Foundation Merit Award, and the Young Scientists Phacilitate Advanced Therapies Award. Dr. Leyfman earned his medical degree from the Penn State College of Medicine, completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, and is completing fellowship training in hematology and oncology at New York-Presbyterian Hospital.
Fellow
Medical School
2021
Residency
Fellowship